Maxicuma®, the proprietary curcumin formulation utilizing LIMAN™ technology, offers superior bioavailability, ensuring higher levels of curcumin remain in its active form (unmetabolized) in the blood plasma. Most of the unformulated curcumin ingredients in the market possess a lower efficacy profile, because curcumin is prone to degradation owing to its inactive metabolites like glucuronide and sulphites upon ingestion and rapid elimination from the body.
